Back to search

National and Kapodistrian University of Athens

Επιπολασμός ιογενούς ηπατίτιδας σε ενεργούς χρήστες τοξικών ουσιών

Abstract

dc:description

BACKGROUND: The aim of the study was to determine the prevalence of serologicalmarkers for viral hepatitis A, B and C among a large group of active IDUs in Greece.METHODS: Between 1997-2007 a total of 2.668 active IDUs (80.77% males, 69%unemployment, 9.93% homeless, 72.94% heroin abusers), who admitted to theEmergency Help and Support Unit of the Greek Organization Against Drugs wereserologically evaluated for viral hepatitis A (anti-HAV), B (HBsAg, antiHBc, antiHBs) andC (anti-HCV), using commercially available methods. Statistical analysis was based onchi-square criterion and logistic regression analysis (STATA 12.1).RESULTS: The age distribution of the study population was: 15-24y (376, 14.09%), 25-34y (971, 36.39%), 35-44y (971, 36.39%), 45-54y (293, 10.98%), 55-64y (47, 1.76%),>65y (10, 0.37%). The overall prevalence of anti-HAV, HBsAg, antiHBc, antiHBsandanti-HCV was 36.21% (966/2668), 3.52% (94/2668), 45.01% (1201/2668), 40.82%(1089/2668) and 72.23% (1927/2668), respectively. The majority of anti-HCV (1137/1927, 59%) and antiHBc(806/1201, 67.11%) positive cases reported injecting druguse beginning before 1991 (p<0.0001). There was a significant reduction in anti-HCVseroprevalence among users who reported injecting drug use beginning in ‘70s (653/762, 85.7%), ‘80s (734/970, 75.6%), ‘90s (404/716, 56.4%) and after 2000 (15/44,34.09%), p<0.001 in all comparisons. Isolated antiHBs positivity was observed in 338(23.04% of the antiHBc-negative) cases, mainly in those who reported injecting drug usebeginning after 1991 (235/338, 69.53% of isolated antiHBs positive cases). There wasalso observed a significant age-related reduction in anti-HAV seroprevalence (p<0.001 inall comparisons).CONCLUSIONS: Although hepatitis C remains the major infectious disease relatedhealth problem among active IDUs , anti-HCV seroepidemiologyis changing during thelast decades. Less than a fourth (23.04%) of the susceptible study population waseffectively vaccinated against hepatitis B whereas the vast majority (>85%) of IDUsyounger than 25 years were unexposed/unvaccinated and susceptible to hepatitis A.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Σέκα, Μαριάννα

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38287

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Σέκα, Μαριάννα. Επιπολασμός ιογενούς ηπατίτιδας σε ενεργούς χρήστες τοξικών ουσιών. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/38287